2Mavrommatis A,TheodoridisT,Orfanidou A,et al.Coagulation system and platelets are fully activated in uncomplicated sepsis.Crit Care Med,2000,28(2):451.
3Meem M, Modak JK, Mortuza R, et al. Biomarkers for diagnosis of neonatal infections:a systematic analysis of their potential as a point-of-care diag- nostics[J]. J Glob Health, 2611,1 (2) : 201-209.
4Camacho-Gonzalez A,Spearman PW,Stoll BJ. Neonatal infectious diseases : evaluation of neonatal sepsis[J]. Pediatr Clin North Am,2013,60 (2): 367-389.
5Murphy K ,Weiner J. Use of leukocyte counts in evaluation of early-onset neonatal sepsisJ]. Pediatr Infect Dis J, 2012,31 ( 1 ) : 16-19.
6Puopolo KM ,Draper D ,Wi S, et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors[J]. Pediatrics, 2011,128 (5) :el 155-1163.
7Hofer N ,Zacharias E ,Mailer W ,et al. An update on the use of C-reactive protein in earlyonset neonatal sepsis:current insights and new tasks [J]. Neonatology, 2012,102 ( 1 ) : 25-36.
8Hotoura E, Giapros V, Kostoula A, et al. Pre-inflammatory mediators and lymphocyte subpopulations in preterm neonates with sepsis[J]. Inflammation, 2012,35(3) : 1094-1101.
9Adly AA, Ismail EA, Andrawes NG, et al. Circulating soluble triggering receptor expressed onmyeloid cells-1 (sTREM-1) as diagnostic and prog- nosticmarker in neonatal sepsis[J]. Cytokine, 2014,65 (2) : 184-191.
10Whicher J, Bienvenu J, Monneret G. Procalcitonin as an acute phase marker[J]. Ann Clin Biochem, 2001,38 (Pt 5 ) :483-493.
